UK first in the world to approve a drug for the treatment of COVID at home

The UK has become the first country in the world to approve the use of a covid-19 drug called molnupiravir. This is reported by the British Medicines and HEALTH Products Regulatory Agency (MHRA).

Molnupiravir is available in capsules, while other medicines certified in the EU or the US are administered intravenously. The drug will be sold in the UK under the brand name Lagevrio. The agency emphasizes its effectiveness and safety, indicating that the drug helps reduce the risk of death and hospitalizations among patients who have mild to moderate disease with a high risk of complications.

FMBA has filed documents for registration of the medicine for CORONAVIRUS "MIR-19" Society

In the group of people who are susceptible to such a development of events, the regulator included those suffering from obesity and diabetes, heart disease and patients over the age of 60 years.

According to clinical trials cited by the regulator, Lagevrio is most effective in the early stages of the disease. For this reason, the agency advised starting the drug as soon as possible after a person has tested positive for COVID-19 or within five days of the onset of symptoms. The regulator warned that Lagervio cannot replace vaccination.

Read together with it: